Abnormal calcium homeostasis in peripheral neuropathies

Cell Calcium

Volumn 47, Issue 2, 2010, Pages 130-139

  Fernyhough, Paul ^a,b   Calcutt, Nigel A ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Axon; Axon degeneration; Calcium channel; Diabetes; Dorsal root ganglia; Insulin; Mitochondria; Neuropathic pain; Neuropathy; Neurotrophic factors; Sensory neurone

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL T TYPE; CALCIUM ION; CONOTOXIN; GABAPENTIN; GLUTAMIC ACID; INSULIN; OMEGA CONOTOXIN MVIIA; PHOSPHATIDYLINOSITOL 3 KINASE; PREGABALIN; PROTEIN KINASE B; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SUBSTANCE P; THIOCTIC ACID;

ANALGESIC ACTIVITY; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CHRONIC PAIN; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG MECHANISM; ENDOPLASMIC RETICULUM; HUMAN; HYPERALGESIA; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL MEMBRANE; NERVE FIBER DEGENERATION; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

EID: 77549084735     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2009.11.008     Document Type: Review

References (148)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
2. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
3. Dawson K.G., Gomes D., Gerstein H., Blanchard J.F., and Kahler K.H. The economic cost of diabetes in Canada, 1998. Diabetes Care 25 (2002) 1303-1307
4. Caro J.J., Ward A.J., and O'Brien J.A. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 25 (2002) 476-481
5. O'Brien J.A., Patrick A.R., and Caro J.J. Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv. Res. 3 (2003) 7
6. Boulton A.J. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47 (2004) 1343-1353
7. Blanchard J.F., Wajda A., and Green C. Diabetes: a Manitoba strategy. Diabetes and its Complications: Forecasting the coming storm (1998), Manitoba Health, Winnipeg
8. Malik R.A., Tesfaye S., Newrick P.G., Walker D., Rajbhandari S.M., Siddique I., Sharma A.K., Boulton A.J., King R.H., Thomas P.K., and Ward J.D. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48 (2005) 578-585
9. Sima A.A. Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide. J. Neurol. Sci. 220 (2004) 133-136
10. Yagihashi S. Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models. J. Peripher. Nerv. Syst. 2 (1997) 113-132
11. Polydefkis M., Hauer P., Sheth S., Sirdofsky M., Griffin J.W., and McArthur J.C. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127 (2004) 1606-1615
12. Sidenius P., and Jakobsen J. Reduced perikaryal volume of lower motor and primary sensory neurons in early experimental diabetes. Diabetes 29 (1980) 182-186
13. Schmidt R.E., Dorsey D., Parvin C.A., Beaudet L.N., Plurad S.B., and Roth K.A. Dystrophic axonal swellings develop as a function of age and diabetes in human dorsal root ganglia. J. Neuropathol. Exp. Neurol. 56 (1997) 1028-1043
14. Kennedy W.R., Wendelschafer-Crabb G., and Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47 (1996) 1042-1048
15. Nja A., and Purves D. The effects of nerve growth factor and its antiserum on synapses in the superior cervical ganglion of the guinea-pig. J. Physiol. 277 (1978) 53-75
16. Vincent A.M., Russell J.W., Low P., and Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 25 (2004) 612-628
17. Oates P.J. Polyol pathway and diabetic peripheral neuropathy. Int. Rev. Neurobiol. 50 (2002) 325-392
18. Thornalley P.J. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int. Rev. Neurobiol. 50 (2002) 37-57
19. Yan S.F., Barile G.R., D'Agati V., Du Yan S., Ramasamy R., and Schmidt A.M. The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications. Curr. Diab. Rep. 7 (2007) 146-153
20. Fernyhough P., and Tomlinson D.R. The therapeutic potential of neurotrophins for the treatment of diabetic neuropathy. Diabetes Rev. 7 (1999) 300-311
21. Ishii D.N. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res. Brain Res. Rev. 20 (1995) 47-67
22. Calcutt N.A., Jolivalt C.G., and Fernyhough P. Growth factors as therapeutics for diabetic neuropathy. Curr. Drug Targets 9 (2008) 47-59
23. Berridge M.J. Calcium microdomains: organization and function. Cell Calcium 40 (2006) 405-412
24. Bezprozvanny I. The inositol 1,4,5-trisphosphate receptors. Cell Calcium 38 (2005) 261-272
25. Hamilton S.L. Ryanodine receptors. Cell Calcium 38 (2005) 253-260
26. Galione A., and Ruas M. NAADP receptors. Cell Calcium 38 (2005) 273-280
27. 2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 32 (2002) 269-278
28. 2+-activated ion channels in exocrine acinar cells. Cell Calcium 38 (2005) 171-200
29. Petersen O.H., Michalak M., and Verkhratsky A. Calcium signalling: past, present and future. Cell Calcium 38 (2005) 161-169
30. Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol. Rev. 85 (2005) 201-279
31. Verkhratsky A. Calcium ions and integration in neural circuits. Acta Physiol. (Oxf.) 187 (2006) 357-369
32. Leist M., and Nicotera P. Calcium and neuronal death. Rev. Physiol. Biochem. Pharmacol. 132 (1998) 79-125
33. Orrenius S., Zhivotovsky B., and Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4 (2003) 552-565
34. Verkhratsky A., and Petersen O.H. The endoplasmic reticulum as an integrating signalling organelle: from neuronal signalling to neuronal death. Eur. J. Pharmacol. 447 (2002) 141-154
35. 2+ homeostasis and neuronal death. J. Cell Mol. Med. 7 (2003) 351-361
36. Paschen W., and Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium 38 (2005) 409-415
37. Levy J., Gavin III J.R., and Sowers J.R. Diabetes mellitus: a disease of abnormal cellular calcium metabolism?. Am. J. Med. 96 (1994) 260-273
38. 2+ transporting pumps. Biochim. Biophys. Acta 1762 (2006) 294-303
39. Kostyuk E., Svichar N., Shishkin V., and Kostyuk P. Role of mitochondrial dysfunction in calcium signalling alterations in dorsal root ganglion neurons of mice with experimentally-induced diabetes. Neuroscience 90 (1999) 535-541
40. Kostyuk E., Voitenko N., Kruglikov I., Shmigol A., Shishkin V., Efimov A., and Kostyuk P. Diabetes-induced changes in calcium homeostasis and the effects of calcium channel blockers in rat and mice nociceptive neurons. Diabetologia 44 (2001) 1302-1309
41. Huang T.J., Sayers N.M., Fernyhough P., and Verkhratsky A. Diabetes-induced alterations in calcium homeostasis in sensory neurones of streptozotocin-diabetic rats are restricted to lumbar ganglia and are prevented by neurotrophin-3. Diabetologia 45 (2002) 560-570
42. Thomas P.K., and Tomlinson D.R. Diabetic and hypoglycaemic neuropathy. In: Dyck P.J., Thomas P.K., Griffin J.W., Low P.A., and Poduslo J.F. (Eds). Peripheral Neuropathy (1992), W.B. Saunders Co., Philadelphia 1219-1250
43. Nilius B., Talavera K., and Verkhratsky A. T-type calcium channels: the never ending story. Cell Calcium 40 (2006) 81-88
44. Hall K.E., Sima A.A., and Wiley J.W. Voltage-dependent calcium currents are enhanced in dorsal root ganglion neurones from the Bio Bred/Worchester diabetic rat. J. Physiol. 486 Pt. 2 (1995) 313-322
45. Kostyuk E., Pronchuk N., and Shmigol A. Calcium signal prolongation in sensory neurones of mice with experimental diabetes. Neuroreport 6 (1995) 1010-1012
46. 2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium 38 (2005) 291-302
47. 2+ release in chromaffin cells seen from inside the ER with targeted aequorin. J. Cell Biol. 144 (1999) 241-254
48. 2+] in the endoplasmic reticulum with aequorin. Cell Calcium 32 (2002) 251-260
49. Solovyova N., and Verkhratsky A. Monitoring of free calcium in the neuronal endoplasmic reticulum: an overview of modern approaches. J. Neurosci. Methods 122 (2002) 1-12
50. 2+ entry. EMBO J. 21 (2002) 622-630
51. 2+ oscillations. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9750-9754
52. Burdakov D., Petersen O.H., and Verkhratsky A. Intraluminal calcium as a primary regulator of endoplasmic reticulum function. Cell Calcium 38 (2005) 303-310
53. 2+ release patterns. FEBS Lett. 580 (2006) 463-468
54. Usachev Y., Shmigol A., Pronchuk N., Kostyuk P., and Verkhratsky A. Caffeine-induced calcium release from internal stores in cultured rat sensory neurons. Neuroscience 57 (1993) 845-859
55. Kano M., Garaschuk O., Verkhratsky A., and Konnerth A. Ryanodine receptor-mediated intracellular calcium release in rat cerebellar Purkinje neurones. J. Physiol. 487 Pt 1 (1995) 1-16
56. 2+. Neuroscience 73 (1996) 1061-1067
57. 2+] recordings in single rat sensory neurones. Pflugers Arch. 446 (2003) 447-454
58. Berridge M.J. Neuronal calcium signaling. Neuron 21 (1998) 13-26
59. Verkhratsky A. The endoplasmic reticulum and neuronal calcium signalling. Cell Calcium 32 (2002) 393-404
60. 2+ signal termination in adult mouse DRG neurones. Neuroreport 5 (1994) 2073-2076
61. Petersen O.H., and Verkhratsky A. Endoplasmic reticulum calcium tunnels integrate signalling in polarised cells. Cell Calcium (2007)
62. Kruglikov I., Gryshchenko O., Shutov L., Kostyuk E., Kostyuk P., and Voitenko N. Diabetes-induced abnormalities in ER calcium mobilization in primary and secondary nociceptive neurons. Pflugers Arch. 448 (2004) 395-401
63. 2+ dyshomeostasis drive neuronal pathology in diabetes. Cell Calcium 44 (2008) 112-122
64. Zherebitskaya E., Akude E., Smith D.R., and Fernyhough P. Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 58 (2009) 1356-1364
65. 2+-ATPase activity in rats with streptozocin-induced diabetes: association with reduced anesthetic requirements. Life Sci. 55 (1994) PL359-PL364
66. 2+-ATPase activity and ionized calcium in type 2 diabetic patients with neuropathy. Diabetes Res. Clin. Pract. 49 (2000) 113-118
67. 2+ channel mRNA in streptozotocin-induced diabetic rat heart. J. Mol. Cell Cardiol. 32 (2000) 655-664
68. 2+ handling in normal and diabetic rat hearts. FASEB J. 16 (2002) 1657-1659
69. Srinivasan S., Stevens M., and Wiley J.W. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49 (2000) 1932-1938
70. Huang T.J., Price S.A., Chilton L., Calcutt N.A., Tomlinson D.R., Verkhratsky A., and Fernyhough P. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52 (2003) 2129-2136
71. Huang T.J., Sayers N.M., Verkhratsky A., and Fernyhough P. Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats. Exp. Neurol. 194 (2005) 279-283
72. Huang T.J., Verkhratsky A., and Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol. Cell Neurosci. 28 (2005) 42-54
73. Nicholls D.G., and Ward M.W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 23 (2000) 166-174
74. Russell J.W., Golovoy D., Vincent A.M., Mahendru P., Olzmann J.A., Mentzer A., and Feldman E.L. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J. 16 (2002) 1738-1748
75. Gumy L.F., Bampton E.T., and Tolkovsky A.M. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol. Cell Neurosci. 37 (2008) 298-311
76. Yu C., Rouen S., and Dobrowsky R.T. Hyperglycemia and downregulation of caveolin-1 enhance neuregulin-induced demyelination. Glia 56 (2008) 877-887
77. Kalichman M.W., Powell H.C., and Mizisin A.P. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol. (Berl.) 95 (1998) 47-56
78. Kamiya H., Zhang W., and Sima A.A. Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats. Diabetologia 49 (2006) 2763-2774
79. Kamiya H., Zhangm W., and Sima A.A. Apoptotic stress is counterbalanced by survival elements preventing programmed cell death of dorsal root ganglions in subacute type 1 diabetic BB/Wor rats. Diabetes 54 (2005) 3288-3295
80. Jiang Y., Nyengaard J.R., Zhang J.S., and Jakobsen J. Selective loss of calcitonin gene-related peptide-expressing primary sensory neurons of the a-cell phenotype in early experimental diabetes. Diabetes 53 (2004) 2669-2675
81. Kennedy J.M., and Zochodne D.W. Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage?. Diabetes 54 (2005) 830-837
82. 2+ signaling. J. Cell Mol. Med. 4 (2000) 164-175
83. Kirichok Y., Krapivinsky G., and Clapham D.E. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 427 (2004) 360-364
84. 2+ release in mouse DRG neurones. Neuroreport 8 (1997) 3929-3932
85. Rizzuto R., Pinton P., Brini M., Chiesa A., Filippin L., and Pozzan T. Mitochondria as biosensors of calcium microdomains. Cell Calcium 26 (1999) 193-199
86. Kopach O., Kruglikov I., Pivneva T., Voitenko N., and Fedirko N. Functional coupling between ryanodine receptors, mitochondria and Ca2+ ATP-ases in rat submandibular acinar cells. Cell Calcium 43 (2008) 469-481
87. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 79 (1999) 1127-1155
88. Gunter T.E., Yule D.I., Gunter K.K., Eliseev R.A., and Salter J.D. Calcium and mitochondria. FEBS Lett. 567 (2004) 96-102
89. 2+ loads in lizard motor nerve terminals. J. Physiol. 509 (1998) 59-65
90. 2+] in mouse motor nerve terminals are limited by mitochondrial uptake and are temperature-dependent. J. Neurosci. 20 (2000) 7290-7296
91. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., and Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287 (2004) C817-C833
92. Coatesworth W., and Bolsover S. Spatially organised mitochondrial calcium uptake through a novel pathway in chick neurones. Cell Calcium 39 (2006) 217-225
93. Nicholls D.G., and Budd S.L. Mitochondria and neuronal survival. Physiol. Rev. 80 (2000) 315-360
94. Singhal A., Cheng C., Sun H., and Zochodne D.W. Near nerve local insulin prevents conduction slowing in experimental diabetes. Brain Res. 763 (1997) 209-214
95. Brussee V., Cunningham F.A., and Zochodne D.W. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 53 (2004) 1824-1830
96. Toth C., Brussee V., and Zochodne D.W. Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia 49 (2006) 1081-1088
97. Francis G., Martinez J., Liu W., Nguyen T., Ayer A., Fine J., Zochodne D., Hanson L.R., Frey II W.H., and Toth C. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes 58 (2009) 934-945
98. Brunet A., Datta S.R., and Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11 (2001) 297-305
99. Fernyhough P., Huang T.J., and Verkhratsky A. Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy. J. Peripher. Nerv. Syst. 8 (2003) 227-235
100. Bouhassira D., Lanteri-Minet M., Attal N., Laurent B., and Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136 (2008) 380-387
101. Veves A., Backonja M., and Malik R.A. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. (Malden, MA) 9 (2008) 660-674
102. Sorkin L.S., and Yaksh T.L. Behavioral models of pain states evoked by physical injury to the peripheral nerve. Neurotherapeutics 6 (2009) 609-619
103. Yaksh T.L. Calcium channels as therapeutic targets in neuropathic pain. J. Pain 7 (2006) S13-S30
104. Gammaitoni A.R., Alvarez N.A., and Galer B.S. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J. Clin. Pharmacol. 43 (2003) 111-117
105. Gover T.D., Moreira T.H., and Weinreich D. Role of calcium in regulating primary sensory neuronal excitability. Handb. Exp. Pharmacol. (2009) 563-587
106. Dogrul A., Gardell L.R., Ossipov M.H., Tulunay F.C., Lai J., and Porreca F. Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 105 (2003) 159-168
107. Bourinet E., Alloui A., Monteil A., Barrere C., Couette B., Poirot O., Pages A., McRory J., Snutch T.P., Eschalier A., and Nargeot J. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J. 24 (2005) 315-324
108. Wen X.-J., Li Z.-J., Chen Z.-X., Fang Z.-Y., Yang C.-X., Li H., and Zeng Y.-M. Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion. Acta Pharmacol. Sin. 27 (2006) 1547-1552
109. Flatters S.J.L., and Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 109 (2004) 150-161
110. Messinger R.B., Naik A.K., Jagodic M.M., Nelson M.T., Lee W.Y., Choe W.J., Orestes P., Latham J.R., Todorovic S.M., and Jevtovic-Todorovic V. In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145 (2009) 184-195
111. Jagodic M.M., Pathirathna S., Nelson M.T., Mancuso S., Joksovic P.M., Rosenberg E.R., Bayliss D.A., Jevtovic-Todorovic V., and Todorovic S.M. Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J. Neurosci. 27 (2007) 3305-3316
112. Willis W.D. Role of neurotransmitters in sensitization of pain responses. Ann. N. Y. Acad. Sci. 933 (2001) 142-156
113. Schroeder J.E., Fischbach P.S., Zheng D., and McCleskey E.W. Activation of mu opioid receptors inhibits transient high- and low-threshold Ca2+ currents, but spares a sustained current. Neuron 6 (1991) 13-20
114. 2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J. Neurosci. 18 (1998) 6319-6330
115. Olivera B.M., Cruz L.J., de Santos V., LeCheminant G.W., Griffin D., Zeikus R., McIntosh J.M., Galyean R., Varga J., and Gray W.R. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry 26 (1987) 2086-2090
116. Malmberg A.B., and Yaksh T.L. Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60 (1995) 83-90
117. Yamamoto T., and Takahara A. Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke. Curr. Topics Med. Chem. 9 (2009) 377-395
118. Fukuizumi T., Ohkubo T., and Kitamura K. Spinal sensitization mechanism in vincristine-induced hyperalgesia in mice. Neurosci. Lett. 343 (2003) 89-92
119. Calcutt N.A., and Chaplan S.R. Spinal pharmacology of tactile allodynia in diabetic rats. Br. J. Pharmacol. 122 (1997) 1478-1482
120. Hall K.E., Liu J., Sima A.A., and Wiley J.W. Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy. J. Neurophysiol. 86 (2001) 760-770
121. 2+ channels in dorsal root ganglia from streptozotocin-induced diabetic mice. Life Sci. 79 (2006) 1995-2000
122. Yusaf S.P., Goodman J., Gonzalez I.M., Bramwell S., Pinnock R.D., Dixon A.K., and Lee K. Streptozocin-induced neuropathy is associated with altered expression of voltage-gated calcium channel subunit mRNAs in rat dorsal root ganglion neurones. Biochem. Biophys. Res. Commun. 289 (2001) 402-406
123. 2+ mobilization and glutamate exocytosis in cerebral synaptosomes from mice. Diabetes Res. Clin. Pract. 81 (2008) e14-e17
124. Iftinca M.C., and Zamponi G.W. Regulation of neuronal T-type calcium channels. Trends Pharmacol. Sci. 30 (2009) 32-40
125. Lowery J.M., Eichberg J., Saubermann A.J., and LoPachin R.M. Distribution of elements and water in peripheral nerve of streptozocin-induced diabetic rats. Diabetes 39 (1990) 1498-1503
126. +-pump activity in rat myelinated nerve fibers. Neuroreport 11 (2000) 2547-2551
127. Siau C., and Bennett G.J. Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth. Analg. 102 (2006) 1485-1490
128. Li F., Obrosova I.G., Abatan O., Tian D., Larkin D., Stuenkel E.L., and Stevens M.J. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E29-E36
129. Ohsawa M., and Kamei J. Role of intracellular calcium in thermal allodynia and hyperalgesia in diabetic mice. Brain Res. 833 (1999) 278-281
130. Shutov L., Kruglikov I., Gryshchenko O., Khomula E., Viatchenko-Karpinski V., Belan P., and Voitenko N. The effect of nimodipine on calcium homeostasis and pain sensitivity in diabetic rats. Cell. Mol. Neurobiol. 26 (2006) 1541-1557
131. Hucho T., and Levine J.D. Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 55 (2007) 365-376
132. Joseph E.K., Chen X., Khasar S.G., and Levine J.D. Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 107 (2004) 147-158
133. Voitenko N.V., Kostyuk E.P., Kruglikov I.A., and Kostyuk P.G. Changes in calcium signalling in dorsal horn neurons in rats with streptozotocin-induced diabetes. Neuroscience 94 (1999) 887-890
134. Milligan E.W.L. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10 (2009) 23-36
135. Tsuda M., Ueno H., Kataoka A., Tozaki-Saitoh H., and Inoue K. Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. Glia 56 (2008) 378-386
136. O'Connor A.B., and Dworkin R.H. Treatment of neuropathic pain: an overview of recent guidelines. Am. J. Med. 122 (2009) S22-S32
137. Dray A. Neuropathic pain: emerging treatments. Br. J. Anaesth. 101 (2008) 48-58
138. Snutch T.P. Targeting chronic and neuropathic pain: the N-type calcium channel comes of age. NeuroRx 2 (2005) 662-670
139. Ziegler D., Nowak H., Kempler P., Vargha P., and Low P.A. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabetic Med. 21 (2004) 114-121
140. Huang S.M., Bisogno T., Petros T.J., Chang S.Y., Zavitsanos P.A., Zipkin R.E., Sivakumar R., Coop A., Maeda D.Y., De Petrocellis L., Burstein S., Di Marzo V., and Walker J.M. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem. 276 (2001) 42639-42644
141. Barbara G., Alloui A., Nargeot J., Lory P., Eschalier A., Bourinet E., and Chemin J. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J. Neurosci. 29 (2009) 13106-13114
142. Lee W.Y., Orestes P., Latham J., Naik A.K., Nelson M.T., Vitko I., Perez-Reyes E., Jevtovic-Todorovic V., and Todorovic S.M. Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway. J. Neurosci. 29 (2009) 9500-9509
143. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., and Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280 (1998) 1831-1836
144. Cesena R.M., and Calcutt N.A. Gabapentin prevents hyperalgesia during the formalin test in diabetic rats. Neurosci. Lett. 262 (1999) 101-104
145. Field M.J., McCleary S., Hughes J., and Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 80 (1999) 391-398
146. Luo Z.D., Calcutt N.A., Higuera E.S., Valder C.R., Song Y.H., Svensson C.I., and Myers R.R. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J. Pharmacol. Exp. Therap. 303 (2002) 1199-1205
147. Maneuf Y.P., Luo Z.D., and Lee K. alpha2delta and the mechanism of action of gabapentin in the treatment of pain. Semin. Cell Dev. Biol. 17 (2006) 565-570
148. Bauer C.S., Nieto-Rostro M., Rahman W., Tran-Van-Minh A., Ferron L., Douglas L., Kadurin I., Sri Ranjan Y., Fernandez-Alacid L., Millar N.S., Dickenson A.H., Lujan R., and Dolphin A.C. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J. Neurosci. 29 (2009) 4076-4088